Articles

Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes

Department of Endocrinology and Metabolism, Academic Medical Centre, Amsterdam, The Netherlands
Department of Medicine, Addenbrooke's Hospital, University of Cambridge, UK
Department of Medical Biochemistry, Academic Medical Centre, Amsterdam, The Netherlands
Department of Medicine, Addenbrooke's Hospital, University of Cambridge, UK
Department of Radiology, Academic Medical Centre, Amsterdam, The Netherlands
Department of Radiology, Academic Medical Centre, Amsterdam, The Netherlands
Department of Medical Biochemistry, Academic Medical Centre, Amsterdam, The Netherlands
Department of Medical Biochemistry, Academic Medical Centre, Amsterdam, The Netherlands
Department of Medicine, Addenbrooke's Hospital, University of Cambridge, UK
Department of Endocrinology and Metabolism, Academic Medical Centre, Amsterdam, The Netherlands
Vol. 97 No. 12 (2012): December, 2012 https://doi.org/10.3324/haematol.2011.059071